[Clinical guideline 'Turner syndrome']

Area of Science:

• Genetics and Endocrinology
• Reproductive Medicine
• Cardiovascular Medicine

Background:

• Turner syndrome is a genetic condition in women characterized by the absence of one X chromosome.
• Key features include short stature and ovarian failure, necessitating lifelong medical supervision.
• Patients face an elevated risk for numerous associated disorders.

Purpose of the Study:

• To update and incorporate recent advancements into clinical guidelines for Turner syndrome management.
• To highlight the evolving role of patients in their own treatment decisions.
• To detail current diagnostic and therapeutic strategies for Turner syndrome.

Main Methods:

• Utilizing Fluorescence In Situ Hybridization (FISH) to detect Y-chromosomal material in 45,X karyotype patients.
• Initiating pubertal induction therapy at the appropriate age when indicated.
• Employing egg donation and vitrification as novel fertility treatment options.
• Implementing regular cardiac and vascular monitoring via echocardiography and MRI to assess risks like aortic dissection.

Main Results:

• Enhanced detection of Y-chromosomal material in specific patient subgroups.
• Timely initiation of pubertal induction therapy improves outcomes.
• New reproductive technologies offer viable fertility options for patients.
• Increased surveillance for cardiovascular complications, particularly aortic dissection, is now standard.

Conclusions:

• Current management of Turner syndrome integrates updated guidelines and patient-centered care.
• Advanced diagnostic techniques and novel therapeutic options improve patient outcomes.
• Specialized centers in the Netherlands and Belgium coordinate comprehensive care for Turner syndrome patients.